Foghorn Therapeutics Says FDA Places Clinical Hold On Phase 1 Dose Escalation Study Of FHD-286

RTTNews | 1079 hari yang lalu
Stocktwits
Foghorn Therapeutics Says FDA Places Clinical Hold On Phase 1 Dose Escalation Study Of FHD-286

(RTTNews) - Biotechnology company Foghorn Therapeutics Inc. (FHTX) announced Tuesday that the U.S. Food and Drug Administration (FDA) has placed a full clinical hold on the Phase 1 dose escalation study of FHD-286, an inhibitor of BRG1/BRM, in relapsed and/or refractory acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS).

The dose escalation Phase 1 study of FHD-286 in metastatic uveal melanoma (mUM) continues per protocol. The company plans to report data from the mUM study in the first half of 2023.

The full clinical hold in the AML/MDS study is due to the observation, in the data submitted in response to the partial hold, of additional suspected cases of fatal differentiation syndrome believed to be associated with FHD-286.

The FDA has additional questions and requires further analyses before the clinical hold may be lifted.

Teg: FHTX
Stocktwits
read more
Bay Street Looks Set To Extend Upmove

Bay Street Looks Set To Extend Upmove

Canadian shares look headed for a positive start on Wednesday, riding on some impressive corporate earnings updates, and higher oil prices. The focus will also be on the developments on the trade front.
RTTNews | 35 minit yang lalu
Eurozone Retail Sales Recover In June

Eurozone Retail Sales Recover In June

Euro area retail sales rebounded in June suggesting that household spending likely supported economic growth in the second quarter, official data revealed on Wednesday. Retail sales grew 0.3 percent on a monthly basis in June, offsetting May's 0.3 percent decline, Eurostat said. However, this was marginally weaker than economists' forecast for a 0.4 percent increase.
RTTNews | 44 minit yang lalu
Euro Rises As European Shares Traded Higher

Euro Rises As European Shares Traded Higher

The euro strengthened against other major currencies in the European session on Wednesday, as European shares traded higher despite weak factory orders data from Germany and fresh tariff threats from U.S. President Donald Trump on pharma and chips. Some upbeat earnings announcements and expectations of a Fed interest rate cut next month appear to be aiding sentiment.
RTTNews | 1j 17min yang lalu
Disney Lifts FY25 EPS View After Q3 Profit Beats Market; ESPN In Deal With WWE, NFL

Disney Lifts FY25 EPS View After Q3 Profit Beats Market; ESPN In Deal With WWE, NFL

Media and entertainment major Walt Disney Co. (DIS) on Wednesday raised fiscal 2025 outlook for earnings.above the Street after reporting significantly higher profit in its third quarter, above market estimates. Meanwhile, revenues missed the market view, despite reporting a growth. Separately, Disney announced that its unit ESPN has signed a landmark rights agreement with WWE.
RTTNews | 1j 34min yang lalu
Dynatrace Boosts FY26 Outlook - Update

Dynatrace Boosts FY26 Outlook - Update

While reporting financial results for the first quarter on Wednesday, software intelligence provider Dynatrace, Inc. (DT) provided its adjusted earnings and revenue guidance for the second quarter and raised its outlook for the full-year 2026.
RTTNews | 1j 40min yang lalu
FTSE 100 Modestly Higher; Hiscox Soars 9%

FTSE 100 Modestly Higher; Hiscox Soars 9%

U.K. stocks are turning in a mixed performance on Wednesday with investors digesting corporate earnings announcements, and continuing to assess the economic impact of the Trump administration's tariffs that are set to become effective this week.
RTTNews | 2j 8min yang lalu
CAC 40 Up In Positive Territory In Cautious Trade

CAC 40 Up In Positive Territory In Cautious Trade

The French market is modestly higher on Wednesday with corporate earnings announcements providing some direction. Despite data showing a sharp drop in French construction sector activity, and fresh concerns about tariffs following U.S. President Donald Trump's fresh tariff threat, the mood is a bit positive amid hopes the Fed will cut interest rate next month.
RTTNews | 2j 39min yang lalu
Euro Rises Against Majors

Euro Rises Against Majors

The euro strengthened against other major currencies in the European session on Wednesday.
RTTNews | 2j 42min yang lalu
Alat
Kalendar Ekonomi
Waktu pasaran
Kadar faedah
Kalendar cuti
Pasaran Forex
Volatiliti Forex
Korelasi Forex
Berita Forex
forex analysis
Data COT
Kecairan
Kalkulator Forex
Peta Panas Forex
Peta haba indikator
Komuniti
Komuniti
Sistem
Sistem Paling Popular
Strategi
Peraduan
Carta Forex
Sentimen Forex
Petunjuk Outlook
Ulasan
Broker
Prop Trading Firms
Perkhidmatan VPS
Penyedia Isyarat
Perkhidmatan Pengaturcaraan EA
Affiliate Programs
Perkhidmatan PAMM Broker
Perkhidmatan Program Rebat
Platform Dagangan
Penasihat Pakar
Pertukaran Kripto
Kursus dagangan
Broker
Spread Forex
Sebut Harga Forex Broker
Pertukaran Broker Forex
Jumlah Broker Forex
Promosi Broker Forex Siaran Akhbar
Platform
Widget
Ciri-ciri
API
RSS
Stock Portfolio
Affiliate Software
Carta Lanjutan
Sokongan
Soalan Lazim
Bantuan
Hubungi Kami
Laporkan pepijat!
Mengenai
Blog
&salin; 2025 Myfxbook Ltd. Hak Cipta Terpelihara.
PERINGATAN RISIKO TINGGI: Perdagangan pertukaran mata wang asing mempunyai risiko tinggi yang mungkin tidak sesuai untuk semua jenis pelabur. Leveraj menimbulkan risiko dan kerugian tambahan. Sebelum anda memutuskan untuk berdagang pertukaran mata wang asing, pertimbangkan dengan teliti objektif pelaburan, tahap pengalaman dan toleransi risiko anda. Anda berkemungkinan kehilangan sebahagian atau semua pelaburan awal anda. Jangan melaburkan wang yang anda tidak mampu untuk kehilangan. Didik diri anda tentang risiko yang berkaitan dengan perdagangan pertukaran asing, dan dapatkan nasihat daripada penasihat bebas kewangan atau cukai jika anda mempunyai sebarang pertanyaan mengenainya. Semua data dan maklumat yang disediakan adalah semata-mata untuk tujuan maklumat, dan bukan bertujuan untuk tujuan perdagangan atau nasihat. Prestasi masa lalu tidak semestinya menunjukkan hasil masa depan.